Type 2 Diabetes Trial, Recruiting NCT06296485 Sponsor: Kaiser Permanente Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06296485
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 75 years or older
  • People who have been diagnosed with Type 2 Diabetes
  • People currently being treated with insulin
  • People who have had episodes of low blood sugar (hypoglycemia) in the past year, either reported by themselves or recorded through medical use
  • People who are able to communicate in English
  • People who are able to use email and the internet

Who may not be able to join:

  • People who are currently on kidney dialysis
  • People who have been diagnosed with dementia
  • People who have a pacemaker or an implanted heart device that automatically corrects heart rhythm (such as an AICD)
  • People who use an insulin pump to manage their diabetes
  • People who have a severe mental illness
  • People who have severe vision impairment
  • People who are currently receiving hospice care
  • People who are currently using or have recently used a continuous glucose monitor (CGM), which is a device that automatically tracks blood sugar levels throughout the day

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Richard W Grant, MD MPH, Kaiser Permanente Northern California - Division of Research

Phone: 866-206-2969

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kaiser Permanente
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
30 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Hypoglycemia aggregate outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov